Stevanato Group S.p.A (STVN) EBITDA Margin (2020 - 2026)
Stevanato Group S.p.A (STVN) posted quarterly EBITDA Margin of 14.14% for Q1 2026, up 65.0% year-over-year from 8.57% in Q1 2025, and down 48.25% quarter-over-quarter from 27.33% in Q4 2025.
Stevanato Group S.p.A (STVN) EBITDA Margin (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported EBITDA Margin for 7 consecutive years, with 14.14% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBITDA Margin rose 65.0% year-over-year to 14.14%; the TTM figure through Mar 2026 stood at 18.92% (up 202.0% YoY), while the FY2025 annual figure was 24.23%, up 232.0% from the prior year.
- EBITDA Margin slipped to 14.14% in Q1 2026 per STVN's latest filing, from 27.33% in the prior quarter.
- Across five years, EBITDA Margin topped out at 27.46% in Q4 2022 and bottomed at 10.72% in Q1 2024.
- Historically, EBITDA Margin has averaged 20.09% across 5 years, with a median of 17.87% in 2022.
- Annual changes were most pronounced in 2022 — EBITDA Margin soared 1303 bps — and 2024, when it plunged 1444 bps.
- Stevanato Group S.p.A's EBITDA Margin stood at 27.46% in 2022, then dropped by 4 bps to 26.23% in 2023, then decreased by 0 bps to 26.19% in 2024, then rose by 4 bps to 27.33% in 2025, then sank by 48 bps to 14.14% in 2026.
- Business Quant data shows STVN's EBITDA Margin at 14.14% in Q1 2026, 27.33% in Q4 2025, and 17.39% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 33.60% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 13.31% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 0.39% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 30.66% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 5.14% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 20.53% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 8.19% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -2.87% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 7.33% |
| 10 | Stevanato Group S.p.A | 6.18 Bn | 6.07 Bn | 100.91 Mn | 12.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.93% |
| Mar 31, 2026 | 14.14% |
| Dec 31, 2025 | 27.33% |
| Sep 30, 2025 | 17.39% |
| Jun 30, 2025 | 14.77% |
| Mar 31, 2025 | 13.49% |
| Dec 31, 2024 | 26.19% |
| Sep 30, 2024 | 14.76% |
| Jun 30, 2024 | 10.79% |
| Mar 31, 2024 | 10.72% |
| Dec 31, 2023 | 26.23% |
| Sep 30, 2023 | 26.42% |
| Jun 30, 2023 | 25.22% |
| Mar 31, 2023 | 17.08% |
| Dec 31, 2022 | 27.46% |
| Sep 30, 2022 | 26.18% |
| Jun 30, 2022 | 25.53% |
| Mar 31, 2022 | 17.87% |
| Dec 31, 2021 | 25.19% |
| Sep 30, 2021 | 13.15% |